Endothelin-1 limits increases in blood flow to native and collateral- dependent myocardium

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 273, Issue 1 42-1, 1997, Pages

  Symons, J David ^a   Rendig, Stephen V ^a   Fu, Liang Wu ^a   Longhurst, John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary circulation; Myocardial ischemia; Swine; Transmural blood flow

Indexed keywords

ENDOTHELIN 1;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW VELOCITY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; HEART MUSCLE BLOOD FLOW; HEART MUSCLE OXYGEN CONSUMPTION; HEART PACING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 33745395876     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1997.273.1.r41     Document Type: Article

References (49)

1. Arai, H., S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
2. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem. Biophys. Res. Commun. 186: 867-873, 1992.
3. Clozel, J. P., and U. Sprecher. Influence of low perfusion pressure on the effects of endothelin on the coronary vascular bed. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H893-H901, 1991.
4. Cohen, M. Coronary Collaterals: Clinical and Experimental Observations. New York: Futura, 1985, p. 1-475.
5. De Nucci, G., R. Thomas, D. D'Orleans-Juste, E. Antunes, C. Walder, T. D. Warner, and J. R. Vane. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA 85: 9797-9800, 1988.
6. Donckier, J., C. Hanet, A. Berbinschi, L. Galanti, A. Robert, H. Van Mechelen, H. Pouleur, and J. M. Ketelslegers. Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circulation 84: 2476-2484, 1991.
7. Dube, S., S. Adabag, and J. M. Canty. Selective blockade of endothelin A receptors causes submaximal vasodilation in isolated coronary resistance arteries (Abstract). FASEB J. 10: A-4678, 1996.
8. Ezra, D., R. E. Goldstein, J. F. Czaja, and G. Z. Feuerstein. Lethal ischemia due to intracoronary endothelin in pigs. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H339-H343, 1989.
9. Glantz, S. P. Primer of Biostatistics (2nd ed.). San Francisco, CA: McGraw Hill, 1987, p. 302-322.
10. Goetz, K. L., B. C. Wang, J. B. Madwed, J. L. Zhu, and R. J. Leadley. Cardiovascular renal and endocrine responses to intravenous endothelin in conscious dogs. Am. J. Physiol. 255 (Regulatory Integrative Comp. Physiol. 24): R1064-R1068, 1988.
11. A receptor. Life Sci. 50: 247-255, 1992.
12. Kiowski, W., G. Sutch, P. Hunziker, J. Kim, E. Oechslin, R. Schmitt, R. Jones, and O. Bertel. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346: 732-736, 1995.
13. Larkin, S. W., J. G. Clarke, B. E. Keogh, L. Araujo, C. Rhodes, G. J. Davies, K. M. Talor, and A. Maseri. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am. J. Cardiol. 64: 956-958, 1989.
14. Lerman, A., F. L. Hildebrand, L. L. Aarhus, and J. C. Burnett. Endothelin has biological actions at pathophysiological concentrations. Circulation 83: 1808-1814, 1991.
15. Longhurst, J. C., G. A. Ordway, and L. M. Buja. Evaluation of coronary native and coronary collateral pressure gradients in the conscious dog. Am. J. Cardiovasc. Pathol. 1: 79-90, 1986.
16. Maruoka, Y., M. D. McKirnan, R. L. Engler, and J. C. Longhurst. Functional significance of alpha-adrenergic receptors in mature coronary collateral circulation in dogs. Am. J. Physiol. 253 (Heart Circ. Physiol. 22): H582-H590, 1987.
17. Masaki, T., J. R. Vane, and P. M. Vanhoutte. International union of pharmacology nomenclature of endothelin receptors. Pharmacol. Rev. 46: 137-142, 1994.
18. Miller, W. L., M. M. Redfield, and J. C. Burnett. Integrated cardiac, renal, and endocrine actions of endothelin. J. Clin. Invest. 83: 317-320, 1989.
19. B-like receptors. Biochem. Biophys. Res. Commun. 105: 511-513, 1992.
20. 2α. Blood Vessels 26: 235-245, 1989.
21. Naruse, M., K. Naruse, and H. Demura. Recent advances in endothelin research on cardiovascular and endocrine systems. Endocr. J. 41: 491-507, 1994.
22. Parker, J. L., P. R. Myers, M. L. Mattox, and A. W. Jones. Impaired vasoconstrictor responses to endothelin in coronary collateral arteries (Abstract). Circulation 82, Suppl. III: III-336, 1990.
23. Pernow, J., and A. Modin. Endothelial regulation of coronary vascular tone in vitro: contribution of endothelin receptor subtypes and nitric oxide. Eur. J. Pharmacol. 243: 281-286, 1993.
24. m) and contractile responses to vasopressin and endothelin in coronary collateral arteries (Abstract). FASEB J. 10: A-3292, 1996.
25. Rooke, G. A., and E. O. Feigl. Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ. Res. 50: 273-286, 1982.
26. Sakurai, T., M. Yanagisawa, Z. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735, 1990.
27. Savage, R. M., B. Guth, F. C. White, A. D. Hagan, and C. M. Bloor. Correlation of regional myocardial blood flow and function with myocardial infarct size during acute myocardial ischemia in the conscious pig. Circulation 64: 699-707, 1981.
28. Schaper, W. Development and role of coronary collaterals. Trends Cardiovasc. Med. 1: 256-261, 1991.
29. Schaper, W., A. Jagneneau, and R. Xhonneux. The development of collateral circulation in the pig and dog heart. Cardiologia 51: 321-325, 1967.
30. Sellke, F. W., Y. Kagaya, R. G. Johnson, T. Shafique, F. J. Schoen, W. Grossman, and R. M. Weintraub. Endothelial modulation of porcine coronary microcirculation perfused via immature collaterals. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1669-H1675, 1992.
31. Sellke, F. W., J. E. Quillen, L. A. Brooks, and D. G. Harrison. Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation 81: 1938-1947, 1990.
32. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89: 1203-1208, 1994.
33. Stewart, D. J., G. Kubac, K. B. Costello, and P. Cernacek. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J. Am. Coll. Cardiol. 18: 38-43, 1991.
34. Symons, J. D., E. Firoozmand, and J. C. Longhurst. Repeated dipyridamole administration enhances collateral-dependent flow and regional function during exercise: a role for adenosine. Circ. Res. 73: 503-513, 1993.
35. Symons, J. D., J. C. Longhurst, and C. L. Stebbins. Response of collateral-dependent myocardium to vasopressin release during exercise. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1644-H1652, 1993.
36. Symons, J. D., K. F. Pitsillides, and J. C. Longhurst. Chronic reduction of myocardial ischemia does not attenuate coronary collateral development in miniswine. Circulation 86: 660-671, 1992.
37. Symons, J. D., S. V. Rendig, L. W. Fu, and J. C. Longhurst. Endothelin (ET) A receptor blockade increases regional myocardial blood flow in left circumflex occluded swine (Abstract). FASEB J. 10: A-324, 1996.
38. Symons, J. D., and C. L. Stebbins. Hemodynamic and regional blood flow responses to nicotine infusion at rest and during exercise. Med. Sci. Sports Exerc. 28: 457-467, 1996.
39. Symons, J. D., and C. L. Stebbins. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin. J. Cardiovasc. Pharmacol. 28: 223-231, 1996.
40. Tonnessen, T., P. A. Naess, K. A. Kirkeboen, J. Offstad, A. IIebekk, and G. Christensen. Release of endothelin from the porcine heart after short term coronary artery occlusion. Cardiovasc. Res. 27: 1482-1485, 1993.
41. Toyo-oka, T., T. Aizawa, N. Suzuki, Y. Hirata, T. Miyauchi, W. S. Shin, M. Yanagisawa, T. Masaki, and T. Sugimoto. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83: 476-483, 1991.
42. Traverse, J. H., D. Judd, and R. J. Bache. Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium. Circulation 93: 558-566, 1996.
43. Wagner, O. F., G. Christ, J. Wojta, H. Vierhapper, S. Parzer, P. J. Nowotony, B. Schneider, W. Wauldhausl, and B. R. Binder. Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem. 267: 16066-16088, 1992.
44. Wang, Q. D., A. Hemsen, X. S. Li, J. M. Lundberg, Y. Uriuda, and J. Pernow. Local overflow and enhanced tissue content of endothelin following myocardial ischemia and reperfusion in the pig: modulation by L-arginine. Cardiovasc. Res. 29: 44-49, 1995.
45. Wang, Q. D., X. S. Li, J. M. Lundberg, and J. Pernow. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig. Cardiovasc. Res. 29: 805-812, 1995.
46. Yanagisawa, M. The endothelin system: a new target for therapeutic intervention. Circulation 89: 1320-1322, 1994.
47. Yanagisawa, M., S. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsuri, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
48. Yang, Z., D. Richard, L. von Segesser, E. Bauer, P. Stulz, M. Turina, and T. F. Luscher. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm? Circulation 82: 188-195, 1990.
49. Yoshida, K., M. Yasujima, M. Kohzuki, M. Kanazawa, K. Yoshinaga, and K. Abe. Endothelin-1 augments the pressor response to angiotensin II infusion in rats. Hypertension 20: 292-297, 1992.